Literature DB >> 9588884

The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.

G Barillari1, L Albonici, O Franzese, A Modesti, F Liberati, P Barillari, B Ensoli, V Manzari, G Santeusanio.   

Abstract

Placenta growth factor type 1 (PIGF-1) can be synthesized by neoplastic cells in an alternative form (PIGF-2) by the addition of basic amino acids to its classic sequence. Here we show that the basic residues of PIGF-2 compete for the binding of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) to heparan sulfate proteoglycans of the cell surface and extracellular matrix. In doing so, PIGF-2 basic sequences inhibit the sequestering of VEGF and bFGF and maintain them in a highly diffusible form, thus enhancing their angiogenic effect. In agreement with these in vitro data, the presence of PIGF-2 transcripts in tumors correlates with their blood vessel number. These results suggest a mechanism by which growth factor isoforms produced by neoplastic cells enhance the formation of new blood vessels supporting tumor growth and progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588884      PMCID: PMC1858577     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.

Authors:  J Folkman; M Klagsbrun; J Sasse; M Wadzinski; D Ingber; I Vlodavsky
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Receptor- and heparin-binding domains of basic fibroblast growth factor.

Authors:  A Baird; D Schubert; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Vascular endothelial growth factor is a secreted angiogenic mitogen.

Authors:  D W Leung; G Cachianes; W J Kuang; D V Goeddel; N Ferrara
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

5.  Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.

Authors:  E W Thompson; S Nakamura; T B Shima; A Melchiori; G R Martin; S Z Salahuddin; R C Gallo; A Albini
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

6.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

7.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

Authors:  B Ensoli; S Nakamura; S Z Salahuddin; P Biberfeld; L Larsson; B Beaver; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

8.  Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.

Authors:  J L Gross; R S Morrison; K Eidsvoog; W F Herblin; P L Kornblith; D L Dexter
Journal:  J Neurosci Res       Date:  1990-12       Impact factor: 4.164

Review 9.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences.

Authors:  E W Raines; R Ross
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  1 in total

1.  Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid.

Authors:  M J Bottomley; N J Webb; C J Watson; L Holt; M Bukhari; J Denton; A J Freemont; P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.